metastatic Merkel Cell Carcinoma (MCC)

metastatic Merkel Cell Carcinoma (MCC) is the indication for 2 drugs in DrugBank. It is covered by 4 curated, structured indications.

Also known as: Metastatic Merkel Cell Carcinoma
Classified under: Endocrine System Diseases
Infections
Neoplasms
Skin and Subcutaneous Tissue Diseases
Indicated drugs: Avelumab
Pembrolizumab

Resolves to

Vocabularies

SNOMED CT1335997000UMLSC5206655

What you can answer from here — as of October 23, 2026

2Indicated drugsWith each drug's targets and mechanism

Listed above

4Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

10Clinical trialsPhase, status and sponsor resolved per trial

1Drug reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for metastatic Merkel Cell Carcinoma (MCC) share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.